ARCHIVES

FDA Likely To Change Procedures For Patient Interaction, Official Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

August 26, 1977

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994

Mail Mixup Delays July 23 Issue

August 6, 1976

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

Clinical Trials Approved By NCI CTEP During May

June 28, 2002